Skip to main content

We at Fortis continuously monitor and evaluate our outcomes for the following procedures and specialities

  • Coronary Artery Bypass Graft (CABG)

    ABOUT THE PROCEDURE

    Coronary Artery Bypass Graft (CABG), commonly known as Heart Bypass surgery/ Coronary Bypass surgery, is a surgical procedure that creates alternate routes for blood to flow to the heart tissue, bypassing the narrowed/blocked arteries (leading to what is known as Coronary Artery Disease). For this purpose, a healthy blood vessel (also called a graft) taken from one area of the patient’s own body is placed around the narrowed/blocked area to restore blood flow to the heart. The goal of this procedure is to relieve symptoms of coronary artery disease (including angina), enable the patient to resume a normal lifestyle, and to lower the risk of a heart attack or other heart problems.

    ABOUT CABG CLINICAL OUTCOMES

    CABG outcome indicators provide measures of the overall success of the surgery and the patient’s post-procedure clinical condition. These parameters are globally accepted evidence-based scientific criteria to indicate the quality of the procedure and the patient’s health status. Fortis hospitals measure the following outcome parameters for CABG, and our performance consistently matches the global benchmarks set by best-in-class hospitals.

    CABG Parameter in 2023 View Previous Year Data
  • Percutaneous Transluminal Coronary Angioplasty (PTCA)

    ABOUT THE PROCEDURE

    Percutaneous coronary intervention (PCI/PTCA), also known as coronary angioplasty, is a nonsurgical technique for treating narrowed/blocked coronary arteries which supply blood to the heart muscle. PTCA involves inserting a tiny balloon or stent across the narrowed part to widen the affected artery and restore blood flow to the heart muscle without requiring an open-heart surgery.

    ABOUT PTCA CLINICAL OUTCOMES

    PTCA outcome indicators provide measures of overall success of the surgery and patient’s post-procedure clinical condition. These parameters are globally accepted evidence-based scientific criteria to indicate quality of procedure and patient’s health status. Fortis hospitals measure the following outcomes parameters for PTCA, and our performance consistently matches the global benchmarks set by best-in-class hospitals.

    PTCA Parameter in 2023 View Previous Year Data
  • Kidney Transplant

    ABOUT THE PROCEDURE

    Kidney transplantation means replacement of the failed kidney with a healthy kidney from another person, called a donor, living or deceased. When kidneys fail to filter fluid and wastes, these may accumulate in the body to the harmful level. When the kidneys have lost about 90 percent of their normal functioning ability, patients have kidney failure (or End-stage Renal Disease) and require either dialysis or transplantation to sustain their life. Kidney transplant provides significant quality-of-life benefits and survival in patients with end-stage kidney disease/Kidney failure/ in this condition.

    ABOUT KTP CLINICAL OUTCOME

    Monitoring of patient survival over longer and defined periods is regarded as successful outcomes of kidney transplant procedure. Acute rejection within the first-year post-transplantation is a negative predictor of long-term renal allograft survival.

    KTP Parameter in 2022 View Previous Year Data
  • Radiation Oncology

    ABOUT THE PROCEDURE

    Radiation is one of the most common treatments for cancer, and is utilised for more than 60% of cancer therapy. It uses carefully measured and optimally controlled high-energy particles or waves, such as x-rays, gamma rays, electron beams or protons aimed to destroy cancer cells in body. This therapy can also be combined with other treatment options like chemotherapy and surgery. The goal is to use this as primary curative treatment for cancer or adjuvant therapy or to prevent recurrence of tumour and improve a person’s quality of life.

    Sometimes in advanced or late-stage of a cancer, it is not possible to destroy all of the tumour cells, then doctors may use palliative radiation therapy to shrink tumours and relieve/reduce pain, pressure and other symptoms.

    ABOUT OUTCOMES

    Every person reacts differently to treatment. Acute radiation toxicities are side effects that may occur during treatment or in the immediate post-treatment period, depending on the type of cancer, location, dose and length of radiation and patient’s general health. Onset may be 2–3 weeks after the commencement of a regimen of radiation therapy. Typically, severity and timing are tied to the total biologic dose and the turnover rate of the tissue in question, respectively.

    Radiation Oncology Parameter in 2023 View Previous Year Data
  • Endoscopic Retrograde Cholangio Pancreatography (ERCP)

    ABOUT THE PROCEDURE

    Endoscopic Retrograde Cholangiopancreatography, also known as ERCP, is a minimally invasive procedure that combines use of X-ray and an endoscope. This procedure is used to diagnose and treat problems of the upper Gastrointestinal Tract and related organs like Liver, Gall Bladder, Bile ducts and Pancreas. It uses a thin, long, flexible, lighted tube called endoscope which is inserted through the mouth and down the throat into the small intestine and a dye (contrast material) is then injected to highlight these organs under X-ray. The procedure is used to detect a block and identify probable cause, or infection in a bile duct or pancreatic duct; and to collect samples of cells or tissue (called a biopsy). Sometimes a stent may be placed through the scope to relieve any blockage in these ducts to allow passage of bile or pancreatic juice onto the intestine.

    ABOUT OUTCOMES

    A commonly performed endoscopic procedure, ERCP is usually safe and well-tolerated, though success of the procedure may vary depending upon various patient and care related factors like age, gender, presence of anatomical variants, previous upper abdominal surgery, the success of the cannulation, technique etc. A higher success rate of biliary cannulation leads to better outcome and lower complications.

    CRCP in 2023 View Previous Year Data
Clinical outcomes of following procedures and specialities are also monitored and shall be published
Mental Health
Caesarean Section
Hysterectomy
Liver Transplant
Total Knee Replacement

View Hospital Wise Clinical Outcome

  • May 2017

    CAD PROM implemented

    ,
    February 2016

    1st in India to publish clinical outcomes data on the website

    ,
    August 2015

    Implementation of ICHOM CAD standard set

    ,
    Jun 2015

    Partnership with Vital Health (ICHOM certified software supplier) 

    ,
    January 2014

    Fortis joins the ICHOM Working Group on Coronary Heart Disease (CAD)

    ,
    January 2013

    Kick-off with Clinical outcomes Monitoring for 3 procedures - CABG, PTCA, KTP

Request callback